Skip to content
Catalyst

resveratrolFinding

Resveratrol decreases systolic blood pressure (setting unspecified)

lowersLimited evidenceFindingreplicated ×2

01 · The sentence it was drawn from

“Resveratrol significantly lowered systolic blood pressure by ~5 mmHg, while resveratrol had no effect on diastolic blood pressure (table 3).”
Quoted verbatim from Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.
This finding among the 88 findings on its endpoint

resveratrol

Systolic blood pressure (setting unspecified)

lowers

Who
11 obese but otherwise healthy men in a randomised double-blind crossover trial with a four-week wash-out
Dose studied
150 mg/day resVida (99% resveratrol) for 30 days

Limited evidencePMID 22055504 · 2011

02 · The study

Study
crossover
Duration
4 weeks

Evidence, by strength

  • strong
  • moderate
  • limitedthis finding
  • very limited
  • insufficient

03 · The paper

Cell metabolism
What else it reported4 findings · 1 compound · 4 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6ZB455JFJS6Z5CWY0WRW7WH